Recent Advances of Ocular Drug Delivery Systems: Prominence of Ocular Implants for Chronic Eye Diseases

被引:13
|
作者
Mostafa, Mahmoud [1 ]
Al Fatease, Adel [2 ]
Alany, Raid G. [3 ,4 ]
Abdelkader, Hamdy [2 ]
机构
[1] Minia Univ, Fac Pharm, Dept Pharmaceut, Al Minya 61519, Egypt
[2] King Khalid Univ, Coll Pharm, Dept Pharmaceut, Abha 62223, Saudi Arabia
[3] Kingston Univ London, Sch Pharm, Kingston Upon Tames KT1 2EE, England
[4] Univ Auckland, Sch Pharm, Auckland 1010, New Zealand
关键词
chronic eye diseases; inserts; implants; ocular delivery; IN-VITRO CHARACTERIZATION; VIVO PHARMACODYNAMIC EVALUATION; NANOSTRUCTURED LIPID CARRIERS; DRY-EYE; SUSTAINED-RELEASE; EX-VIVO; MACULAR DEGENERATION; OPHTHALMIC DELIVERY; HYALURONIC-ACID; AQUEOUS-HUMOR;
D O I
10.3390/pharmaceutics15061746
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chronic ocular diseases can seriously impact the eyes and could potentially result in blindness or serious vision loss. According to the most recent data from the WHO, there are more than 2 billion visually impaired people in the world. Therefore, it is pivotal to develop more sophisticated, long-acting drug delivery systems/devices to treat chronic eye conditions. This review covers several drug delivery nanocarriers that can control chronic eye disorders non-invasively. However, most of the developed nanocarriers are still in preclinical or clinical stages. Long-acting drug delivery systems, such as inserts and implants, constitute the majority of the clinically used methods for the treatment of chronic eye diseases due to their steady state release, persistent therapeutic activity, and ability to bypass most ocular barriers. However, implants are considered invasive drug delivery technologies, especially those that are nonbiodegradable. Furthermore, in vitro characterization approaches, although useful, are limited in mimicking or truly representing the in vivo environment. This review focuses on long-acting drug delivery systems (LADDS), particularly implantable drug delivery systems (IDDS), their formulation, methods of characterization, and clinical application for the treatment of eye diseases.
引用
收藏
页数:50
相关论文
共 50 条
  • [41] Recent trends and updates on ultradeformable and elastic vesicles in ocular drug delivery
    Srivastava, Vaibhavi
    Singh, Vivek
    Khatri, Dharmendra Kumar
    Mehra, Neelesh Kumar
    DRUG DISCOVERY TODAY, 2023, 28 (08)
  • [42] Implants as drug delivery devices for the treatment of eye diseases
    da Silva, Gisele Rodrigues
    Fialho, Silvia Ligorio
    Siqueira, Rubens Camargo
    Jorge, Rodrigo
    Cunha Junior, Armando da Silva
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 46 (03) : 585 - 595
  • [43] Sustained release ocular drug delivery systems for glaucoma therapy
    Al-Qaysi, Zinah K.
    Beadham, Ian G.
    Schwikkard, Sianne L.
    Bear, Joseph C.
    Al-Kinani, Ali A.
    Alany, Raid G.
    EXPERT OPINION ON DRUG DELIVERY, 2023, 20 (07) : 905 - 919
  • [44] A Review on Newer Ocular Drug Delivery Systems with an Emphasis on Glaucoma
    Peter, Maneesha
    Panonnummal, Rajitha
    ADVANCED PHARMACEUTICAL BULLETIN, 2021, 11 (03) : 399 - 413
  • [45] Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye
    Fangueiro, Joana F.
    Veiga, Francisco
    Silva, Amelia M.
    Souto, Eliana B.
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (09) : 1135 - 1146
  • [46] Recent advances in ocular lubrication
    Zhang, Jianhua
    Su, Yunjuan
    Wu, Jian
    Wang, Hongdong
    FRICTION, 2024, 12 (09) : 1929 - 1954
  • [47] Innovative Nanotechnology in Drug Delivery Systems for Advanced Treatment of Posterior Segment Ocular Diseases
    Wu, Yue
    Li, Xin
    Fu, Xueyu
    Huang, Xiaomin
    Zhang, Shenrong
    Zhao, Nan
    Ma, Xiaowei
    Saiding, Qimanguli
    Yang, Mei
    Tao, Wei
    Zhou, Xingtao
    Huang, Jinhai
    ADVANCED SCIENCE, 2024, 11 (32)
  • [48] Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases
    Bachu, Rinda Devi
    Chowdhury, Pallabitha
    Al-Saedi, Zahraa H. F.
    Karla, Pradeep K.
    Boddu, Sai H. S.
    PHARMACEUTICS, 2018, 10 (01)
  • [49] Recent advances in drug delivery systems for glaucoma treatment
    Patel, K. D.
    Silva, L. Barrios
    Park, Y.
    Shakouri, T.
    Keskin-Erdogan, Z.
    Sawadkar, P.
    Cho, K. J.
    Knowles, J. C.
    Chau, D. Y. S.
    Kim, H-W
    MATERIALS TODAY NANO, 2022, 18
  • [50] The prominence of the dosage form design to treat ocular diseases
    Campos, Patricia Mazureki
    Petrilli, Raquel
    Lopez, Renata F., V
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 586